• ქართული
  • English
  • Keytruda powers Merck to first-quarter beat

    (Reuters) – Drugmaker Merck & Co reported a better-than-expected first-quarter profit on Tuesday and raised its adjusted earnings forecast for the year, helped by a more than 150 percent rise in sales of cancer drug Keytruda.

    Market Quotes by TradingView